Testosterone promotes glucose intolerance, lipid disorder and oxidative stress in type 1 diabetic rats

Journal of Basic and Clinical Physiology and Pharmacology

Volumn 25, Issue 1, 2014, Pages 13-20

  Morakinyo, Ayodele Olufemi ^a   Adekunbi, Daniel Abiodun ^a   Dada, Kayode Akanni ^a   Adegoke, Olufeyi Adefunke ^a  

^a UNIVERSITY OF LAGOS   (Nigeria)

Author keywords

Diabetes; Glucose tolerance; Lipid; Oxidative stress; Testosterone

Indexed keywords

ALLOXAN; CATALASE; GLUCOSE; GLUTATHIONE; INSULIN; LIPID; MALONALDEHYDE; SUPEROXIDE DISMUTASE; TESTOSTERONE; GLUCOSE BLOOD LEVEL;

ANDROGEN DEFICIENCY; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; DIET RESTRICTION; DISEASE PREDISPOSITION; ENZYME ACTIVITY; EXPERIMENTAL RAT; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; ORCHIECTOMY; OXIDATIVE STRESS; RAT; SPRAGUE DAWLEY RAT; ANIMAL; BLOOD; COMPLICATION; DEFICIENCY; EXPERIMENTAL DIABETES MELLITUS; GLUCOSE TOLERANCE TEST; METABOLISM;

ANIMALS; BLOOD GLUCOSE; CATALASE; DIABETES MELLITUS, EXPERIMENTAL; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; GLUTATHIONE; INSULIN; LIPIDS; MALE; MALONDIALDEHYDE; ORCHIECTOMY; OXIDATIVE STRESS; RATS; SUPEROXIDE DISMUTASE; TESTOSTERONE;

EID: 84898648711     PISSN: 07926855     EISSN: 21910286     Source Type: Journal    
DOI: 10.1515/jbcpp-2012-0072     Document Type: Article

References (37)

1. Kaufman JM, Vermeulen A. The decline of androgen levels in elderly men and its clinical therapeutic implication. Endocrinol Rev 2005;26:833-76.
2. Mayfield J. Diagnosis and classification of diabetes mellitus: new criteria. Am Acad Fam Phys 1998;58:1355-62.
3. Kim J, Kil IS, Seok YM, Kim DK, Lim DG, Park J, et al. Orchiectomy attenuates post-ischemic oxidative stress and ischemia/reperfusion injury in mice J Biol Chem 2006;281:20349-56.
4. Natella F, Succini C. Role of coffee in modulating diabetes risk. Nutr Rev 2012;70:207-17.
5. Stellato RK, Feldman HA, Hamdy O, Horton ES, McKinlay JB. Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study. Diabetes Care 2000;23:490-4.
6. Selvin E, Feinleib M, Zhang L, Rohrmann S, Rifai N, Nelson W, et al. Androgens and diabetes in men. Diabetes Care 2007;30:234-8.
7. Dhindsa S, Prabhakar S, Sethi M, Bandyopadhyay A, Chaudhuri A, Dandona P. Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes. J Clin Endocrinol Metab 2004;89:5462-8.
8. Laaksonen DE, Niskanen L, Punnonen K, Nyyssonen K, Tuomainen TP, Salonen R, et al. Sex hormones, inflammation and the metabolic syndrome: A population-based study. Eur J Endocrinol 2003;149:601-8.
9. Kupelian V, Page ST, Araujo AB. Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in non-obese men. J Clin Endocrinol Metab 2006;91:843-50.
10. Oh JY, Barrett-Connor E, Wedick NM, Wingard DL. Rancho Bernardo Study. Endogenous sex hormones and the development of type 2 diabetes in older men and women; the Rancho Bernardo study. Diabetes Care 2002;25:55-60.
11. Corona G, Mannucci E, Petrone L, Ricca V, Balercia G, Mansani R, et al. Association of hypogonadism and type II diabetes in men attending an outpatient erectile dysfunction clinic. Int J Impotence Res 2006;18:190-7.
12. Phillips GB, Jing T, Heymsfield SB. Relationships in men of sex hormones, insulin, adiposity, and risk factors for myocardial infarction. Metabolism 2003;52:784-90.
13. NIH. Guide for the care and use of laboratory animals. DHHS, PHS, NIH Publication No. 85-23, 1985.
14. Morakinyo AO, Akindele AJ, Zabeer A. Modulation of antioxidant enzymes and inflammatory cytokines: possible mechanism of antidiabetic effect of ginger extracts. Afr J Biomed Res 2011;14:195-202.
15. Covington DS, Xue H, Pizini R. Streptozotocin and alloxan are comparable agents in the diabetic model of impaired wound healing. Diabetes Res 1993;23:47-53.
16. Oloyo AK, Sofola OA, Anigbogu CN. Orchiectomy attenuates impaired endothelial effects of a high-salt diet in Sprague- Dawley rats. Can J Pharmacol 2011;89:1-9.
17. Gonzales RJ, Krause DN, Duckles SP. Testosterone suppresses endothelium-dependent dilation of rat middle cerebral arteries. Am J Physiol Heart Circ Physiol 2004;286:552-60.
18. Zhu J, Yu M, Friesema J, Huang T, Roman RJ, Lombard JH. Salt induced ANG II suppression impairs the response of cerebral artery smooth muscle cells to prostacyclin. Am J Physiol Heart Circ Physiol 2005;288:908-13.
19. Ariful I, Afia A, Rafiqul IK, Sarowar H, Khurshid A, Ibne W, et al. Oral glucose tolerance test (OGTT) in normal control and glucose induced hyperglycemic rats with Coccinia cordifolia L and Catharanthus roseus L. Pak J Pharm Sci 2009;22:402-4.
20. Morakinyo AO, Iranloye BO, Daramola AO, Adegoke OA. Antifertility effect of calcium channel blockers on male rats: Association with oxidative stress. Adv Med Sci 2011;56:1-8.
21. Uchiyama M, Mihara M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 1978;86:271-8.
22. Van Dooran, R, Liejdekker CM, Handerson PT. Synergistic effects of phorone on the hepatotoxicity of bromobenzene and paracetamol in mice. Toxicology 1978;11:225-33.
23. Sun M, Zigman S. An improved spectrophotometric assay for superoxide dismutase based on ephinephrine autoxidation. Anal Biochem 1978;90:81-9.
24. Aebi H. Catalase in vitro. Methods Enzymol 1984;105:121-6.
25. Dockery F, Bulpitt CJ, Agarwal S, Donaldson M, Rajkumar C. Testosterone suppression in men with prostate cancer leads to an increase in arterial stiffness and hyperinsulinaemia. Clin Sci 2003;104:195-201.
26. Nishiyama T, Ishizaki F, Anraku T, Shimura H, Takahashi K. The influence of androgen deprivation therapy on metabolism in patients with prostate cancer. J Clin Endocrinol Metab 2005;90:657-60.
27. Pagotto U, Gambineri A, Pelusi C, Genghini S, Cacciari M, Otto B, et al. Testosterone replacement therapy restores normal ghrelin in hypogonadal men. J Clin Endocrinol Metab 2003;88:4139-43.
28. Veloso DF, Alberti LR, Figueiredo JA, Rodrigues FH, Petroianu A. Morphological, metabolic and functional repercussions after orchiectomy in rats. J Clin Endocrinol Metab 2009;7:131-6.
29. Tchernof A, Labrie F, Belanger A, Prud'homme D, Bouchard C, Tremblay A, et al. Relationship between endogenous steroid hormone, sex hormone-binding globulin and lipoprotein levelsin men; contribution of visceral obesity, insulin levels and other metabolic variables. Atherosclerosis 1997;133:235-44.
30. Alexandersen P, Christiansen C. The aging male: Testosterone deficiency and testosterone replacement. Atherosclerosis 2004;173:157-69.
31. Dominguez C, Ruiz E, Gussinye M, Carrascosa A. Oxidative stress at onset and in early stages of type 1 diabetes in children and adolescent. Diabetes Care 1998;21:1736-42.
32. Suryawanshi AP, Bhutey AK, Nagdeote AN, Jadhar AA, Manoorkar GS. Study of lipid peroxide and lipid profile in diabetic mellitus. Ind J Clin Biochem 2006;21:126-30.
33. Jin L, Xue XY, Jin LJ, Li SY, Xu YP. Antioxidant and pancreasprotective effect of aucubin on rats with streptozotocin-induced diabetes. Eur J Pharmacol 2008;582:162-7.
34. Jakus V. The role of free radicals, oxidative stress and antioxidant systems in diabetic vascular disease. Bratisl Lek Listy 2000;101:541-51.
35. Quinn PG, Payne AH. Steroid product-induced oxygenmediated damage of microsomal cytochrome P-450 in Leydig cell cultures. Relationship to desensitization. J Biol Chem 1985;260:2092-9.
36. Peltola V, Huhtaniemi I, Metsa-Ketela M, Ahotupa M. Induction of lipid peroxidation during steroidogenesis in the rat testes. Endocrinology 1996;137: 105-12.
37. Chen H, Zirkin BR. Long-term suppression of Leydig cell steroidogenesis prevents Leydig cell aging. Proc Natl Acad Sci USA 1999;96:14877-81.